A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

Completed

Plain-English translation of NCT04124965 on ClinicalTrials.gov ↗ · Source last updated September 2023 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(43 sites)

United States

Mg0004 50081, Phoenix, Arizona

Mg0004 50072, Los Angeles, California

Mg0004 50088, Washington D.C., District of Columbia

Mg0004 50120, Miami, Florida

Mg0004 50073, Tampa, Florida